Late-Onset Bioprosthetic Mitral Valve Thrombosis, Presenting with Significant Obstruction and Acute Heart Failure. [PDF]
Cardoso AF +5 more
europepmc +1 more source
Screening, Diagnosis and Management of Atrial Fibrillation in Cancer Patients: Current Evidence and Future Perspectives. [PDF]
Gonçalves-Teixeira P +9 more
europepmc +1 more source
Effectiveness of an educational intervention on knowledge about anticoagulant therapy: a quasi-experimental study. [PDF]
Nascimento MOD +7 more
europepmc +1 more source
Challenges in Performing Real-World Evidence Studies in Low-Middle Income Countries: the EdoBRA Study. [PDF]
Massaro AR.
europepmc +1 more source
Mechanical Mitral Valve Thrombosis in a Patient with COVID-19 Infection. [PDF]
Aruğaslan E +5 more
europepmc +1 more source
Position Statement on the Management of Antithrombotic and Anticoagulant Therapy in Dengue - 2026. [PDF]
Pitta FG +24 more
europepmc +1 more source
Polymorphism of the CYP2C9 and VKORC1 genes in patients on the public health system of a municipality in Southern Brazil. [PDF]
Colet C +4 more
europepmc +1 more source
Relationship between anxiety and depressive symptoms and social support in patients with atrial fibrillation. [PDF]
Monteiro ADS +6 more
europepmc +1 more source
Prognosis and Characteristics Associated with Prosthetic Valve Thrombosis: Insights from a Brazilian Study. [PDF]
Dutra GP, Gomes BFO.
europepmc +1 more source
Busca ativa na avaliação das causas de internação por evento adverso a varfarina
Varfarina é um medicamento potencialmente perigoso e considerado um fármaco entre os dez mais associados a eventos adversos graves. As complicações hemorrágicas são os eventos mais comuns relacionados a este anticoagulante oral em emergências.
Oliveira, Priscilla Garcia de
core

